search
Back to results

Noninvasive Brain Stimulation for Stroke (NIBSstroke)

Primary Purpose

Stroke

Status
Suspended
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
tdcs (ELDITH, Neuroconn, Ilmenau, Germany)
Sponsored by
University Hospital of Mont-Godinne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring stroke

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • stroke with at least slight deficit

Exclusion Criteria:

  • epilepsy
  • contraindication to tDCS and/or to fMRI
  • presence of metal in the head
  • unability to understand / complete behavioural tasks
  • chronic intake of alcohol or recreative drugs
  • major health condition
  • presence of pacemaker
  • pregnancy

Sites / Locations

  • Department of Neurology, CHU Mont-Godinne

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Real stimulation

Sham stimulation

Arm Description

real NIBS

sham NIBS

Outcomes

Primary Outcome Measures

change in function before/after tDCS
any brain function impaired by stroke

Secondary Outcome Measures

change in neuroimaging and neurophysiological before/after tDCS
noninvasive neuroimaging : brain activity studied by means of fMRI noninvasive neurophysiological measure : TMS, EEG,evoked potentials, EMG

Full Information

First Posted
December 23, 2011
Last Updated
May 8, 2023
Sponsor
University Hospital of Mont-Godinne
search

1. Study Identification

Unique Protocol Identification Number
NCT01503073
Brief Title
Noninvasive Brain Stimulation for Stroke
Acronym
NIBSstroke
Official Title
Noninvasive Brain Stimulation for Stroke Improvement
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Suspended
Study Start Date
January 2008 (Actual)
Primary Completion Date
December 2025 (Anticipated)
Study Completion Date
December 2030 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital of Mont-Godinne

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Noninvasive brain stimulations will be used in acute and chronic stroke patients to improve a variety of functions.
Detailed Description
Noninvasive brain stimulations (NIBS) will be used in acute and chronic stroke patients to improve a variety of functions such as motor functions, cognitive functions, ... NIBS will be applied in a placebo-controlled, double-blind, randomised fashion. Behavioural data will be collected before and after NIBS, as well as brain functional imaging data.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
stroke

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Real stimulation
Arm Type
Active Comparator
Arm Description
real NIBS
Arm Title
Sham stimulation
Arm Type
Sham Comparator
Arm Description
sham NIBS
Intervention Type
Device
Intervention Name(s)
tdcs (ELDITH, Neuroconn, Ilmenau, Germany)
Intervention Description
transcranial direct current stimulation
Primary Outcome Measure Information:
Title
change in function before/after tDCS
Description
any brain function impaired by stroke
Time Frame
Before intervention, immediately after intervention, 10-20-30-40-50-60 min after intervention; long-term after intervention : 1-2-3-4 weeks, 2-3-4-5-6-7-8-9-10-11-12 months
Secondary Outcome Measure Information:
Title
change in neuroimaging and neurophysiological before/after tDCS
Description
noninvasive neuroimaging : brain activity studied by means of fMRI noninvasive neurophysiological measure : TMS, EEG,evoked potentials, EMG
Time Frame
Before intervention, immediately after intervention, 10-20-30-40-50-60 min after intervention; long-term after intervention : 1-2-3-4 weeks, 2-3-4-5-6-7-8-9-10-11-12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: stroke with at least slight deficit Exclusion Criteria: epilepsy contraindication to tDCS and/or to fMRI presence of metal in the head unability to understand / complete behavioural tasks chronic intake of alcohol or recreative drugs major health condition presence of pacemaker pregnancy
Facility Information:
Facility Name
Department of Neurology, CHU Mont-Godinne
City
Yvoir
State/Province
Namur
ZIP/Postal Code
5530
Country
Belgium

12. IPD Sharing Statement

Citations:
PubMed Identifier
33175411
Citation
Elsner B, Kugler J, Pohl M, Mehrholz J. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke. Cochrane Database Syst Rev. 2020 Nov 11;11(11):CD009645. doi: 10.1002/14651858.CD009645.pub4.
Results Reference
derived
PubMed Identifier
23486918
Citation
Lefebvre S, Thonnard JL, Laloux P, Peeters A, Jamart J, Vandermeeren Y. Single session of dual-tDCS transiently improves precision grip and dexterity of the paretic hand after stroke. Neurorehabil Neural Repair. 2014 Feb;28(2):100-10. doi: 10.1177/1545968313478485. Epub 2013 Mar 13.
Results Reference
derived

Learn more about this trial

Noninvasive Brain Stimulation for Stroke

We'll reach out to this number within 24 hrs